| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.5M | -67.4% |
| R&D Expense | $29.4M | +39.0% |
| SG&A Expense | $16.2M | +7.6% |
| Operating Income | -$42.1M | -64.8% |
| Pre-tax Income | -$242.0M | -280.8% |
| Income Tax | $0 | — |
| Net Income | -$242.0M | -280.8% |
| EPS (Basic) | -$32.37 | -49.4% |
| EPS (Diluted) | -$32.37 | -49.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.2M | +158.2% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $91.6M | +135.2% |
| Total Assets | $98.7M | +103.7% |
| Current Liabilities | $9.9M | +35.7% |
| Total Liabilities | $286.5M | +310.2% |
| Stockholders' Equity | -$187.8M | -778.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.2M | -71.6% |
| Capital Expenditures | $128K | +392.3% |
| Investing Cash Flow | -$128K | -392.3% |
| Financing Cash Flow | $85.1M | +425.8% |
| Free Cash Flow | -$30.4M | -72.0% |